Expiring federal contract
HHSN275201700002C — The Emmes Company, LLC
Department of Health and Human Services · National Institutes of Health
- Contract / PIID
- HHSN275201700002C
- Incumbent
- The Emmes Company, LLC
- Incumbent UEI
- NBQCBJ6FXBU4
- Current end date
- May 28, 2027
- Potential total value
- $66,032,644
- Obligated
- $66,032,644
- NAICS
- 541711 — Research and Development in Biotechnology
- PSC
- AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- Set-aside
- Full & Open
- Start date
- July 28, 2017
- Place of performance
- MD
- Award type
- DEFINITIVE CONTRACT
Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.
What the contract covers
IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT
Likely rebid window (estimate)
- Sources Sought / RFI: about May 2026 – Nov 2026 (6–12 months before the end date)
- RFP: about Jan 2027 – Mar 2027 (2–4 months before the end date)
Now inside the estimated Sources Sought / RFI window.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: 1 recorded change to the end date, value or incumbent. Sign up to see each one.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 541711)
- 75N93022F00001 — University Of North Carolina At Chapel Hill · ends November 30, 2026 · $1.7M
- 75N93019F00132 — The Emmes Company, LLC · ends December 31, 2026 · $174K
- HHSN27500007 — Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center · ends December 31, 2026 · $12M
- HHSO100201600017C — Dnae Group Holdings Limited · ends December 31, 2026 · $43M
- 75N93024F00002 — University Of Texas Medical Branch At Galveston · ends January 17, 2027 · $3.3M
- HHSO100201600009C — Cerus Corporation · ends March 31, 2027 · $185M
- 75N93019F00131 — University Of Alabama At Birmingham · ends April 30, 2027 · $8.8M
- 75N93024F00001 — Trustees Of Tufts College · ends July 10, 2027 · $823K
- HHSO100201700020C — Regeneron Pharmaceuticals INC · ends September 25, 2027 · $279M
- HHSO100201700012C — Merck Sharp & Dohme LLC · ends September 27, 2027 · $236M